Antonis Antoniou, PhD
Researchers have yet to determine the degree to which harboring a BRCA1
mutation raises a woman’s lifetime risk of developing breast and ovarian cancer. A recent study is now offering more insight in this area by estimating the age at which BRCA1/2
-positive women are most at risk.
“We will then be able to combine all the findings to provide more personalized information on the age-specific cancer risks, and help women decide on the timing and on the options to use to reduce their risk of cancer,” he said.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
... to read the full story